Quintiles has appointed Jim McDermott as managing director of the market intelligence practice for the consulting group. McDermott has more than 30 years of biopharm experience, a third of which was spent at Decision Resources.
Ellen Morgan is to step down as president and CEO of Synteract. Morgan co-founded Synteract and will now serve as chairman. Stewart Bieler, chief operating officer (COO), will lead Synteract on an interim basis while the search for a new president and CEO is conducted.
MPI Research has named Tim Derrington as president and COO. Derrington last worked as CEO and chairman of Axient Research and has also held positions at BioReliance and Quintiles.
David Flick has joined CTI Clinical Trial and Consulting Services as information technology support specialist. Flick joins CTI from Robert Half Technology where he worked on projects for TriHealth.
Metrics has hired David Varley as director of manufacturing operations. Varley has 30 years of pharmaceutical manufacturing experience from working at Burroughs Wellcome, Glaxo Wellcome, ER Squibb, Purdue Pharmaceuticals, and, most recently, BioDelivery Sciences.
David Gill has been appointed chief financial officer at INC Research. Gill served as board member and chairman of INC from 2007 and 2010 and has also worked at Transenterix.
American Peptide Company has named John McKinley as senior marketing manager. McKinley joins from Bachem and has a genetics degree from University of California, Berkeley.
Brian Scanlan has been promoted to president and CEO of Cambridge Major Laboratories (CML), succeeding Michael Major who is to retire having led the company for 11 years. Scanlan joined CML in 2002 and rose to the position of chief business officer.